Kevin Herde

Kevin Herde

Director of Finance/CFO at MARAVAI LIFESCIENCES HOLDINGS, INC.

Net worth: 3 M $ as of 2024-03-30

53 year
Health Technology
Commercial Services
Consumer Services

Profile

Kevin M. Herde occupies the position of Chief Financial Officer for Maravai Lifesciences Holdings, Inc. Mr. Herde previously was Chief Financial Officer & Executive Vice President of Sorrento Therapeutics, Inc., Vice President-Global Blood Screening at Hologic, Inc. and Vice President & Controller of Gen-Probe, Inc. (a subsidiary of Hologic, Inc.) and Manager-Audit at KPMG LLP. Kevin M. Herde received an undergraduate degree from the University of San Diego.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-03-14 332,914 ( 0.25% ) 3 M $ 2024-03-30

Kevin Herde active positions

CompaniesPositionStart
MARAVAI LIFESCIENCES HOLDINGS, INC. Director of Finance/CFO 2017-04-30
All active positions of Kevin Herde

Former positions of Kevin Herde

CompaniesPositionEnd
SORRENTO THERAPEUTICS, INC. Director of Finance/CFO 2017-05-14
Comptroller/Controller/Auditor 2011-12-31
Corporate Officer/Principal -
HOLOGIC, INC. Corporate Officer/Principal -
See the detail of Kevin Herde's experience

Training of Kevin Herde

University of San Diego Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kevin Herde's experience

Connections

74

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
HOLOGIC, INC.

Health Technology

SORRENTO THERAPEUTICS, INC.

Health Technology

MARAVAI LIFESCIENCES HOLDINGS, INC.

Health Technology

Private companies2

Health Technology

Commercial Services

See company connections